ArticleCureus2026
Medication Adherence to Antidiabetic Therapy Among Patients With Tuberculosis and Diabetes in Ratlam District, Madhya Pradesh, India: A Facility-Based, Descriptive Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective Tuberculosis (TB) and diabetes mellitus frequently co-occur in India and complicate the management of both conditions. Nevertheless, there is limited evidence on adherence to antidiabetic therapy among adults receiving TB care at district-level public health facilities. This study aimed to assess the levels of medication adherence and identify patient-reported barriers among adults with TB and diabetes attending two TB facilities in Ratlam district, Madhya Pradesh, India. Methods The facility-based cross-sectional descriptive study was derived from a parent research project conducted between January 2023 and December 2023 at the District Tuberculosis Centre and the TB Clinic of Government Medical College, Ratlam. Consenting adults aged over 18 years with newly diagnosed TB and coexisting diabetes were eligible. A pretested, structured questionnaire containing adherence and self-management items was used to collect data, and the current manuscript presents descriptive statistics. Results Out of the 135 respondents, 88 (65.2%) were men. The largest age group was 61 to 70 years (41.5%). Adherence to antidiabetic therapy was found to be low (80 participants, 59.3%), moderate (35 participants, 25.9%), and high (20 participants, 14.8%). Financial constraints (36.1%), medication side effects (26.2%), and the complexity of treatment regimens (18.3%) were the most commonly reported barriers to adherence. The majority of the participants received antidiabetic medicines in government institutions (78.5%). Conclusions The lack of adherence to antidiabetic therapy was widespread among adults with TB and diabetes in this setting. The most common barriers reported were financial barriers, adverse effects, and regimen complexity. These results support the need for improved adherence measurement and practical assistance in combined TB-diabetes care, and larger analytical studies are needed to identify independent determinants of nonadherence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.